VACCINE
|
WHEN TO GIVE
|
DOSE
|
ROUTE/SITE
|
FOR INFANTS
|
|||
BCG
|
At birth or ASAP till 1 year
|
0.1 ml (0.05 ml in less then 1 month age )
|
ID/Left upper Arm
|
OPV
|
OPV-0 at birth or ASAP within first 15 days
OPV1- @ 6 weeks
OPV2- @10 weeks
OPV3- @14 weeks
|
2 drops
|
PO
|
D.P.T.
|
DPT1- @6weeks
DPT2 - @10 weeks
DPT3- @14 weeks
|
0.5ml
|
IM/Antero-lateral side of mid thigh
|
Hepatitis B
|
HB-0 @ birth
HB1 - @ 6 weeks
HB2- @ 10 weeks
HB3- @14 weeks
|
0.5ml
|
IM/Antero-lateral side of mid thigh
|
Measles
|
@ 9 months
|
0.5ml
|
SC/Right upper arm
|
Vitamin A (1st Dose)
|
@9 months with measles
|
1ml (1 lakh IU)
|
PO
|
FOR CHILDREN
|
|||
DPT Booster
|
16-24 months
5-6 years
|
0.5ml
|
IM/Antero-lateral side of mid thigh
IM/Upper Arm
|
OPV Booster
|
16-24 months
|
2 drops
|
PO
|
Vitamin- A (2nd to 9th dose
)
|
16 months
Then one dose/month upto 5 years
|
2ml (2lakh IU)
|
PO
|
TT
|
10 and 16 years
|
0.5 ml
|
IM/Upper Arm
|
Japanese Encephalitis
|
16-24 months
|
0.5ml
|
SC/Left upper Arm
|
FOR PREGNANT
WOMEN
|
|||
TT1
|
Early Pregnancy
|
0.5 ml
|
IM/Upper arm
|
TT2
|
4 weeks after TT1
|
0.5 ml
|
IM/Upper arm
|
TT-Booster
|
If received 2 TTdoses in a pregnancy within last 3 years*
|
0.5 ml
|
IM/Upper arm
|
·
PO- Per Oral
·
IM –Intra Muscular
·
ID- Intra Dermal
·
ASAP- As soon as Possible
·
Japanese Encephalitis is only in endemic areas
Manipalnursingmitra.rajbai.org
Update:-
Update:-
Key updates and major
changes in recommendations for IAP Immunization Timetable, 2016
MMR and MMRV vaccines
- · Three doses of MMR at 9 months, 15 months, and between 4-6 years
- · No stand alone measles dose at 9 months;
- · MMRV is approved for use at 4-6 years of age only
Polio immunization
- · The 'alternative' two-dose schedule of 8 and 16 weeks for IPV to be preferred over 3-dose schedule for primary immunization;
- · A full dose of IM-IPV for children who had already received 2 ID-fIPV doses at 6 and 14 weeks or single dose of IM-IPV at 14 weeks
- · An interval of at least 8 weeks to be maintained between the additional dose and the last dose of ID or IM-IPV;
- · No change in the booster dose schedule of IPV, and OPV immunization schedule;
Typhoid immunization
- · PedaTyph®, the other typhoid conjugate vaccine is now approved for prevention of typhoid fever in children;
- · Both the typhoid conjugate vaccines, i.e. Typbar-TCV® and PedaTyph® to have the same administrative schedule;
- · Typhoid conjugate vaccine to be preferred over Vi-polysaccharide vaccine for both booster dose and catch-up vaccination;
- · No change in the booster recommendations;
- · Additional updates on typhoid conjugate vaccines provided
Japanese encephalitis
vaccination
·
The recommended age for Japanese encephalitis
(JE) vaccination raised to 18 years in endemic regions.
Varicella vaccines
·
A review along with grading of the available
brands of monovalent varicella vaccine presented;
·
All the available vaccine brands are approved
for use in pediatric population for prevention of varicella;
·
Varilrix® and Variped® score over other brands
as far as the evidence on efficacy and safety is concerned
Other updates and
changes
- · A brief update on the new dengue vaccine, CYD-TDV (Dengvaxia®) is offered
- · A new accreditation policy for evaluation of different brands of a licensed vaccine in the country is announced;
- · The comments and footnotes for several vaccines are also updated and revised.
COMMENTS